Deep learning enables pathologist-like scoring of NASH models

Non-alcoholic fatty liver disease (NAFLD) and the progressive form of non-alcoholic steatohepatitis (NASH) are diseases of major importance with a high unmet medical need. Efficacy studies on novel compounds to treat NAFLD/NASH using disease models are frequently evaluated using established histolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinemann, Fabian, Birk, Gerald, Stierstorfer, Birgit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895116/
https://www.ncbi.nlm.nih.gov/pubmed/31804575
http://dx.doi.org/10.1038/s41598-019-54904-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895116/
https://www.ncbi.nlm.nih.gov/pubmed/31804575
http://dx.doi.org/10.1038/s41598-019-54904-6

Ejemplares similares